Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Melanin-concentrating Hormone Receptor (MCHR)-KRX-104130
KRX-104130

Chemical Structure : KRX-104130

CAS No.: 1332364-25-6

KRX-104130 (KRX104130)

Catalog No.: PC-22854Not For Human Use, Lab Use Only.

KRX-104130 is a potent melanin-concentrating hormone receptor 1 (MCHR1) antagonist with IC50 of 0.02 uM, shows no cardiotoxicity.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

KRX-104130 is a potent melanin-concentrating hormone receptor 1 (MCHR1) antagonist with IC50 of 0.02 uM, shows no cardiotoxicity.
KRX-104130 increased the expression of low-density lipoprotein receptor (LDLR), which induced cholesterol reduction in the gene expression analysis.
KRX-104130 showed a protective effect by reducing hepatic lipid accumulation, liver injury, and histopathological changes in NASH mouse model.

Physicochemical Properties

M.Wt 466.49
Formula C24H24F2N6O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

1-(1-((1H-indol-2-yl)methyl)piperidin-4-yl)-3-(6,7-difluoro-3-methoxyquinoxalin-2-yl)urea

References

1. Lim G, et al. Int J Mol Sci. 2022 Mar 30;23(7):3807.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: